Coexpression of Vimentin and Cytokeratins in Human Melanoma Cell Lines
- Authors: Bogush T.A.1, Kaliuzhny S.A.1, Basharina A.A.1, Bogush E.A.1, Kirsanov V.Y.2, Kosorukov V.S.1, Burova O.S.1, Davydov M.M.2, Baryshnikova M.A.1
-
Affiliations:
- Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation
- Sechenov First Moscow State Medical University
- Issue: Vol 74, No 6 (2019)
- Pages: 296-299
- Section: Article
- URL: https://bakhtiniada.ru/0027-1314/article/view/164045
- DOI: https://doi.org/10.3103/S0027131419060075
- ID: 164045
Cite item
Abstract
Abstract—Molecular heterogeneity in seven human metastatic melanoma cells lines is revealed using a double immunofluorescent assay by flow cytometry. It is evaluated that quite a small population of cells (up to 10%) expressed only vimentin, the main marker of melanoma. Only epithelial cytokeratins expression is revealed in a significantly greater number of cells (from 25 to 50%). The dominant molecular phenotype (50–80% cells expressed both markers), the coexpression of vimentin and cytokeratins, is identified for the first time. The authors assume that the latter phenotype of melanoma cells may be a molecular marker of the tumor’s aggressiveness and metastatic potential.
Keywords
About the authors
T. A. Bogush
Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation
Author for correspondence.
Email: tatbogush@mail.ru
Russian Federation, Moscow
S. A. Kaliuzhny
Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation
Email: tatbogush@mail.ru
Russian Federation, Moscow
A. A. Basharina
Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation
Email: tatbogush@mail.ru
Russian Federation, Moscow
E. A. Bogush
Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation
Email: tatbogush@mail.ru
Russian Federation, Moscow
V. Yu. Kirsanov
Sechenov First Moscow State Medical University
Email: tatbogush@mail.ru
Russian Federation, Moscow
V. S. Kosorukov
Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation
Email: tatbogush@mail.ru
Russian Federation, Moscow
O. S. Burova
Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation
Email: tatbogush@mail.ru
Russian Federation, Moscow
M. M. Davydov
Sechenov First Moscow State Medical University
Email: tatbogush@mail.ru
Russian Federation, Moscow
M. A. Baryshnikova
Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation
Email: tatbogush@mail.ru
Russian Federation, Moscow
Supplementary files
